Artificial intelligence and surgery
- PMID: 38250693
- PMCID: PMC10797843
- DOI: 10.1002/ags3.12766
Artificial intelligence and surgery
Conflict of interest statement
Yuko Kitagawa received lecture fees from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd, Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Factory Inc., Shionogi & Co., Ltd., Nippon Covidien Inc., Ono Pharmaceutical Co., Ltd., Bristol‐Myers Squibb K. K. Author Y. K was supported by grants from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd, Yakult Honsha Co. Ltd., Asahikasei Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Tsumura & Co., Kyouwa Hakkou Kirin Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., EA Pharma Co., Ltd., Astellas Pharma Inc., Toyama Chemical Co., Ltd., Medicon Inc., Kaken Pharmaceutical Co., Ltd., Eisai Co., Ltd., Otsuka Pharmaceutical Factory Inc., Teijin Pharma Ltd., Nihon Pharmaceutical Co., Ltd., and Nippon Covidien Inc. Author Y. K held an endowed chair provided by Chugai Pharmaceutical Co., Ltd., and Taiho Pharmaceutical Co., Ltd, outside the submitted work. Masashi Takeuchi has stocks from Direava inc. outside the submitted work. Author Yuko Kitagawa is a current chief editor of Annals of Gastroenterological Surgery.
References
-
- Takeuchi M, Collins T, Lipps C, Haller M, Uwineza J, Okamoto N, et al. Towards automatic verification of the critical view of the myopectineal orifice with artificial intelligence. Surg Endosc. 2023;37(6):4525–4534. - PubMed
Publication types
LinkOut - more resources
Full Text Sources